Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic risk factors for sclerotic graft-versus-host disease.

Blood - 15 Sept 2016

Inamoto Yoshihiro, Martin Paul J, Flowers Mary E D, Lee Stephanie J, Carpenter Paul A, Warren Edus H, Geraghty Daniel E, Lee Ni, Boeckh Michael J, Storer Barry E, Levine David M, Fan Wenhong, Zhao Lue-Ping, Hansen John A

Abstract excerpt

Sclerotic graft-versus-host disease (GVHD) is a distinctive phenotype of chronic GVHD after allogeneic hematopoietic cell transplantation, characterized by fibrosis of skin or fascia. Sclerotic GVHD has clinical and histopathological similarities with systemic sclerosis, an autoimmune disease whose risk is influenced by genetic polymorphisms. We examined 13 candidate single-nucleotide polymorphisms (SNPs) that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to B-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft vs Host Disease

Share to Histocompatibility Testing

Share to HLA-DP alpha-Chains

Share to Sclerosis

Share to Skin Diseases

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 27313329
DOI: 10.1182/blood-2016-05-715342
PMCID: PMC5025901

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic risk factors for sclerotic graft-versus-host disease.PMID 27313329Read ↗

Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models.Semantic proximity Read ↗

Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.Semantic proximity Read ↗

From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases.Semantic proximity Read ↗

Genomic and genetic studies of systemic sclerosis: A systematic review.Semantic proximity Read ↗

The genetics of scleroderma: looking into the postgenomic era.Semantic proximity Read ↗

Multiple single-nucleotide polymorphism-based risk model for clinical outcomes after allogeneic stem-cell transplantation, especially for acute graft-versus-host disease.Semantic proximity Read ↗

Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease.Semantic proximity Read ↗

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.Semantic proximity Read ↗

Scleroderma.Semantic proximity Read ↗

Identification of fibroinflammatory and fibrotic transcriptomic subsets of human sclerotic cutaneous chronic graft-versus-host diseaseSemantic proximity Read ↗

Biologic markers of chronic GVHD.Semantic proximity Read ↗

The genetics of scleroderma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.